期刊文献+

APE1shRNA重组质粒的构建及对人乳腺癌细胞生长的影响 被引量:3

Construction of APE1 gene specific short hairpin RNA expressing plasmid and effect on growth of human breast carcinoma cell
下载PDF
导出
摘要 目的设计构建靶向脱嘌呤脱嘧啶核酸内切酶1(APE1/ref-1)特异性短发卡RNA的真核表达载体,并转染人乳腺癌T47D细胞。方法设计、合成针对APE1的特异性的短链寡核苷酸,构建APE1特异性shRNA的重组质粒,稳定转染人乳腺癌T47D细胞;采用聚合酶链反应和免疫印迹法检测转染前后T47D细胞中APE1的表达。采用四甲基偶氮唑盐法观察T47D细胞的生长情况。结果经酶切和测序鉴定,成功构建APE1特异性shRNA的重组质粒,并能够转染T47D细胞。转染后,APE1在mRNA和蛋白水平表达分别下降约53.1%和60.5%,T47D细胞增殖活性受到抑制。结论运用pGenesil-1.1质粒载体构建的靶向APE1特异性shRNA的重组质粒可以成功转染T47D细胞,有效抑制APE1的表达,并抑制肿瘤细胞的生长。 Objective To investigated the effect of short hairpin RNA(shRNA) targeting Apurinic/Apyrimidinic Endonuclease 1(APE1) on the human breast carcinoma T47D cell line.Methods The shRNA targeting APE1 was constructed and transfected into T47D cells through LipofectamineTM 2000.The mRNA and protein levels of APE1 were detected by RT-PCR and Western-blot.Cell proliferation was examined by MTT.Results The APE1-shRNA expression plasmid was successfully constructed and transfected into T47D cells.The expression inhibition rate was about 53.1% at mRNA level and the expression inhibition rate was about 60.5% at protein level.The cell proliferation was also lower because of the APE1-shRNA.Conclusions An APE1-shRNA expression,which we constructed by pGenesil-1.1,can be sucessfully transfected into T47D cells.It can inhibit the expression of APE1,suppress the growth of T47D cells.
出处 《实用肿瘤杂志》 CAS 北大核心 2010年第5期523-527,共5页 Journal of Practical Oncology
基金 天津市应用基础及前沿技术研究计划(08JCYBJC05500)
关键词 乳腺肿瘤 RNA 短发卡 脱嘌呤脱嘧啶核苷酸内切酶1 基因表达 逆转录聚合酶链反应 免疫印迹法 breast neoplasms RNA short hairpin Apurinic/Apyrimidinic Endonuclease 1 gene expression reverse transcriptase polymerase chain reaction immunoblotting
  • 相关文献

参考文献13

  • 1Puglisi F, Barbone F,Tell G, et al. Prognostic role of Ape/ Ref-1 subcelhtlar expression in stage I-III breast carcinomas [ J ]. Oncol Rep ,2002,9 ( 1 ) : 11 - 17.
  • 2Ouellet V, Le Page C, Guyot MC, et al. SET complex in serous epithelial ovarian cancer [ J-. Int J Cancer,2006, 119(9) :2119 -2126.
  • 3Puglisi F, Aprile G, Minisini AM, et al. Prognostic significance of Apel/ref -1 subcellular localization in non- small cell lung carcinomas [ J ]. Anticancer Res,2001,21(6A) :4041 - 4049.
  • 4Yang D, Buchholz F, Huang Z, et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells [J]. Proc Natl Acad Sci USA,2002,99 (15) :9942 - 9947.
  • 5Scherr M, Morgan MA, Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells [ J ]. Curt Med Chem,2003,10 ( 3 ) : 245 - 256.
  • 6周洲,姜政,周静,陶小红,黄爱龙,王丕龙.shRNA沉默多药耐药胃癌细胞7901/VCR MDR1基因表达的实验研究[J].实用肿瘤杂志,2009,24(3):227-232. 被引量:3
  • 7Shankar P, Manjunath N, Lieberman J. The prospect of silencing disease using RNA interference [ J ]. JAMA, 2005,293( 11 ) : 1367 - 1373.
  • 8Evans AR, Limp-Foster M, Kelley MR. Going APE over ref-1 [J]. Mutat Res,2000,461(2) :83 - 108.
  • 9Robertson KA, Bullock HA, Xu Y, et al. Altered expression of ApelJref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation [ J ]. Cancer ires, 2001,61 (5) : 2220 - 2225.
  • 10Luo M, Delaplane S, Jiang A, et al. Role of the multifunctional DNA repair and redox signaling protein Apel/Ref-1 in cancer and endothelial ceUs: small- molecule inhibition of the redox function of Apel [ J ]. Antioxid Redox Signal,2008,10( 11 ) :1853 -1867.

二级参考文献19

  • 1Shi H,Lu D,Shu Y,et al.Expression of multidrug-resistance-related proteins P-glycoprotein,gluta-thione-S-transferases,topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma[J].Cancer Invest,2008,26(4):344-351.
  • 2Kamata S,Kishimoto T,Kobayashi S,et al.Expression and localization of ATP binding cassette (ABC) family of drug transporters in gastric hepatoid adenocarcinomas[J].Histopathology,2008,52(6):747-754.
  • 3Zhang D,Fan D.Multidrug resistance in gastric cancer:recent research advances and ongoing therapeutic challenges[J].Exp Rev Anticancer Ther,2007,7(10):1369-1378.
  • 4Ramesh S,Shanthi P,Krishnan KB,et al.Multidrug resistance 1 gene expression in Indian patients with gastric carcinoma[J].Indian J Gastroenterol,2003,22(1):19-21.
  • 5Li X,Fan R,Zou X,et al.Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA[J].Mol Biol (Mosk),2008,42(1):102-109.
  • 6Stege A,Priebsch A,Nieth C,et al.Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference[J].Cancer Gene Ther,2004,11(11):699-706.
  • 7Yuan H,Li X,Wu J,et al.Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance[J].Curr Med Chem,2008,15(5):470-476.
  • 8Mechetner E.Detection of the MDR1 P-glycoprotein expression and function[J].Methods Mol Biol,2007,378:175-193.
  • 9Saeki M,Kurose K,Tohkin M,et al.Identification of the functional vitamin D response elements in the human MDR1 gene[J].Biochem Pharmacol,2008,76(4):531-542.
  • 10Ren Y,Wang Y,Zhang Y,et al.Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide-Doxorubicin conju-gate in vitro and in vivo[J].Mol Pharm,2008,5(4):579-587.

共引文献2

同被引文献19

  • 1杨镇洲,陈幸华,王东,向德兵,张曦,张沁宏.多发性骨髓瘤患者APE1蛋白表达的临床意义[J].第三军医大学学报,2005,27(6):554-556. 被引量:8
  • 2Montagut C,Rovira A,Albanell J.The proteasome:a novel target for anticancer therapy[J].Clin Transl Oncol,2006,8(5):313-317.
  • 3Andrew F,Cun-Yu W.Proteasome Inhibitor Induces Apoptosis through Induction of Endoplasmic Reticulum Stress[J].Cancer Biol Ther,2006,5(7):745-748.
  • 4Yang M,Huang J,Pan HZ,et al.Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells[J].International journal of moLecular medicine,2008,22(4):489-496.
  • 5Hideshima T,Ikeda H,Chauhan D,et al.Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cells[J].Blood,2009,114(5):1046-1052.
  • 6Chauhan D,Hideshima T,Mitsiades C.Proteasome inhibitor therapy in multiple myeloma[J].MoL Cancer Ther,2005,4(4):686-692.
  • 7Shapovalov Y,Benavidez D,Zuch D,et al.Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma[J].Int J Cancer,2010,127(1):67-76.
  • 8Yang JL,Yang D,Cogdell D,et al.APEX1 Gene Amplification and Its Protein Overexpression in Osteosarcoma:Correlation with Recurrence,Metastasis,and Survival[J].Technology in Cancer Research and Treatment,2010,9(2):161-169.
  • 9Wang D,Xiang DB,Yang XQ,et al.APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells[J].Lung Cancer,2009,66(3):298-304.
  • 10Wang D,Luo M,Kelley MR.Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma:enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition[J].MoL Cancer Ther,2004,3(6):679-683.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部